EXERT-BCN: An Exercise and Nutrition Regimen to Designed to Improve Body Composition After Treatment for Breast Cancer (EXERT-BCN)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05978960 |
Recruitment Status :
Recruiting
First Posted : August 7, 2023
Last Update Posted : August 7, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Breast Cancer | Other: Nutrition and resistance training exercise intervention | Not Applicable |
Excess adipose tissue is a risk factor for the diagnosis of breast cancer and is also associated with an increased risk of disease recurrence.1 Additionally weight gain during and after treatment for breast cancer is associated with a higher risk of recurrence, distant metastases, and death.2 More specifically, low muscle mass and increased adipose tissue is associated with poorer outcomes after the treatment of breast cancer.3 Yet, most women gain significant weight during and after breast cancer treatment, potentially compromising outcomes.
Effective methods to promote weight loss and improve metabolic and hormonal dysregulation, inflammation, and body composition in the breast cancer setting are urgently needed. In the noncancer setting, the promotion of high-quality diets that avoided processed food and simple carbohydrates in the DIETFITS study promoted weight loss4. However, this dietary strategy and others were utilized to result in weight loss, but do not necessarily consider maximizing body composition, i.e., muscle mass preservation or increase, and adipose tissue loss.
The major, and some would consider only, non-pharmacological method to increase muscle mass is via resistance training with an adequate stimulus and quantity to elicit and promote hypertrophy.5 Our group has already shown that profound muscle hypertrophy is attainable in a population of women undergoing treatment for breast cancer, particularly when the dose threshold of load and repetitions is met. At interim analysis, this program revealed a 2 lb. increase in muscle mass and a 6 lb. decrease in adipose tissue after a 3 month program utilizing linear progression.
Based on the DIEFITS protocol which has been described as a "healthy low-carbohydrate" diet, participants will be advised to eat nutrient dense food sources high in vitamins, minerals, and nutrients. Participants will be told to limit processed foods, sugar, bread, pasta, and other simple carbohydrates. Participants will be advised to eat plenty of colorful and nonstarchy vegetables. Finally, participants will be told to avoid snacking between meals, cook most/all meals, eat with family and friends, avoid eating food in the car or on the run, and focus on whole foods that require preparation. This protocol resulted in significant weight loss at one year. Additionally, the lack of calculations and quantification of calories leaves this as a more user-friendly option for participants.
The exercise regimen from EXERT-BC has yet to be combined with a dietary intervention. Thus, the following protocol will assess our resistance training regimen in conjunction with a nutrition intervention similar to the DIETFITS Protocol. This will allow adequate assessment of whether we can optimize body composition in these individuals with both exercise and dietary changes.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 44 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | An EXErcise Regimen Designed to Improve Body Composition, Functional Capacity, and Strength After Treatment for Breast Cancer With Nutrition Optimization |
Actual Study Start Date : | May 20, 2023 |
Estimated Primary Completion Date : | May 20, 2024 |
Estimated Study Completion Date : | August 20, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: Resistance training with high quality low-carbohydrate nutrition regimen
The regimen will consist of an intense resistance training program with linear progression and the goal of increase strength, mobility, muscle mass, and functional capacity. The nutrition program will avoid calorie counting, and instead focus on quality, while maximizing protein and limiting carbohydrates.
|
Other: Nutrition and resistance training exercise intervention
3 month 2-3 times/week, 60 min exercise regimen utilizes compound movements to focus on body composition, strength, and mobility. Classes are run by certified strength and conditioning specialists and adjusted for linear progression and safety, progressing from compound to isolated movements to maximize safety. The nutrition intervention focuses on dietary quality by following a "healthy low-carbohydrate" diet, focusing on nutrient dense foods high and avoiding processed foods and simple carbohydrates to keep totals under 100g/day. Participants will be advised to eat vegetables, avoid snacking, cook all meals with family and friends, avoid eating on the run, and focus on whole foods that require preparation. Calculations and quantification of calories will be avoided, while protein consumption goals are 1.3-1.8 g/kg per. Dietary strategy will be continuously discussed during exercise sessions and the PI will have twice monthly meetings with participants. |
- Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via bioimpedance analysis [ Time Frame: 3 months ]Measurement on bioimpedance analysis machine (Inbody 970)
- Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via ultrasound [ Time Frame: 3 months ]Measurement via ultrasound and calculation with Jackson-Pollack calculations
- Determine changes in bone mineral concentration in pounds from before to after the nutrition and exercise regimen [ Time Frame: 3 months ]Measurement on bioimpedance analysis machine (Inbody 970)
- Determine changes in GAD7 anxiety score from before to after the nutrition and exercise regimen [ Time Frame: 3 months ]GAD7 asks 8 questions rated from 0 to 3
- Determine changes in PHQ9 depression score from before to after the nutrition and exercise regimen [ Time Frame: 3 months ]PHQ9 asks 10 questions rated from 0 to 3
- Determine changes in EQ-5D responses 1-5 and overall score from before to after the nutrition and exercise regimen [ Time Frame: 3 months ]EQ-5D asks 5 questions rates from 1-5 and an overall rating of health
- Determine changes in strength via load measured in pounds from before to after the nutrition and exercise regimen [ Time Frame: 3 months ]Load is calculated by multiplying sets by repetitions by weight lifted for a specific exercise
- Determine changes in Y-balance score for each leg [ Time Frame: 3 months ]Y-balance score adds up the distance each leg can move in the front and side directions, divided by the length of the hip. This correlates inversely with fall risk.
- Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen [ Time Frame: 3 months ]Functional movement screen (FMS) is a 7 movement test where an individual can score from 0 to 21
- Determine changes in resting metabolic rate in kilocalories/day from before to after the nutrition and exercise regimen [ Time Frame: 3 months ]Measurement via VO2 Master indirect calorimeter
- Determine changes in muscle mass in pounds from before to after the nutrition and exercise regimen [ Time Frame: 3 months ]Measurement on bioimpedance analysis machine (Inbody 970)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 89 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 20-89 years
- Women with a biopsy proven diagnosis of ductal carcinoma in situ or invasive carcinoma of the breast.
- Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Treatment with targeted agents and immunotherapy is allowed.
Exclusion Criteria:
- Any current treatment with chemotherapy for breast cancer
- Inability to get and down off the ground or squat body weight
- Inability to safely engage in group sessions
- Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05978960
Contact: Samantha Campbell | (412) 330-6151 | samantha.campbell@ahn.org |
United States, Pennsylvania | |
AHN CI Exercise Oncology and Resiliency | Recruiting |
Pittsburgh, Pennsylvania, United States, 15202 | |
Contact: Colin E Champ 412-734-7605 colin.champ@ahn.org | |
Principal Investigator: Colin E Champ, MD, CSCS | |
Sub-Investigator: Christopher L Peluso, MS, CSCS | |
Sub-Investigator: Christie Hilton, DO |
Responsible Party: | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) |
ClinicalTrials.gov Identifier: | NCT05978960 |
Other Study ID Numbers: |
2023-131-SG |
First Posted: | August 7, 2023 Key Record Dates |
Last Update Posted: | August 7, 2023 |
Last Verified: | July 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | Undecided at this point |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
breast cancer nutrition body composition |
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |